TP53 and neoplasm: Since HPVs can bypass immune systems, and MDM4 polymorphisms can modulate the apoptotic capacity though p53 pathway, both molecular pathways eventually controlling the HPV clearance through escape of immune surveillance, subsequently affecting the tumor HPV status [31].